The Use of Apomorphine in Parkinson 's Disease

Haşmet A. HANAĞASI, Gülüstü KAPTANOĞLU, Murat EMRE

Issue: 2001, Volume 7 - Issue 2
0 339

THE USE OF APOMORPHINE IN PARKINSON'S DISEASE

Haşmet A. HANAĞASI, Gülüstü KAPTANOĞLU, Murat EMRE

Issue: 2001, Volume 7 - Issue 1
0 350

Ablative surgery in Parkinson's Disease: A Long-Term Follow-up of 18 Patients

Sibel ERTAN, Hülya APAYDIN, Şakir DELİL, Sibel ÖZEKMEKÇİ, Orhan BARLAS

Issue: 2000, Volume 6 - Issue 1
0 303

Effect of General Anesthesia on the Emergence of Parkinson's Disease

M. Cenk AKBOSTANCI, Funda TAN, Sıla USAR, Hatice BALABAN, Nermin MUTLUER

Issue: 2000, Volume 6 - Issue 1
0 372

Middle Latency Somatosensory Evoked Potentials in Hemiparkinsonism

A. SOYSAL, F. ÖZER, B. ARPACI

Issue: 1999, Volume 5 - Issue 2
0 289

Peripheral and Cortical Silent Period in Parkinson's Disease and Effects of L-DOPA

Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA

Issue: 1998, Volume 4 - Issue 3-4
0 326

Movement Related Cortical Potentials and L-DOPA in Parkinson 's Disease

Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA

Issue: 1998, Volume 4 - Issue 3-4
0 330

H-Reflex Recovery Ratios for Alfa Motor Neuron Excitability in Parkinson's Disease

Ayhan ÖZTÜRK, Hilmi UYSAL

Issue: 1998, Volume 4 - Issue 3-4
0 350

New Developments in Parkinson's Disease Management

M. Cenk AKBOSTANCI

Issue: 1998, Volume 4 - Issue 1-2
0 312

P300 and P300 Topographic Mapping in Parkinson's Disease

Raif ÇAKMUR, Fethi İDİMAN, Barış BAKLAN, Birsen KESKİN, Görsev YENER, Şakir FADILOĞLU

Issue: 1995, Volume 1 - Issue 4
0 336

THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS

Bülent ELİBOL

Issue: 1995, Volume 1 - Issue 1
0 334

Assesment of quality of life in neurological diseases

Sibel Karşıdağ, Yasemin Ekmekyapar Fırat, Fettah Eren, Sibel Canbaz Kabay, Murat Terzi

DOI: 10.4274/tnd.2023.56649

Issue: 2024, Volume 30 - Issue 1
2421 1175

Epigenetic analysis of heat shock activator complex in the peripheral blood of Parkinson's disease patients and its clinical significance

Yagmur İnalkac Gemici, Irem Tasci, Muhammed Dundar, Nazmi Ozgen, Nefsun Danis, Harika Gozde Gozukara, Ahmet Koc

DOI: 10.55697/tnd.2024.110

Issue: 2024, Volume 30 - Issue 2
1041 719

Impact of a 12-week structured exercise program on motor function and exosomal alpha-synuclein levels in Parkinson's disease: A prospective analysis

Nihat Mustafayev, Abdulkadir Tunç, Birsen Elibol, Kamer Unal Eren, Sule Terzioglu-Usak

DOI: 10.55697/tnd.2024.8

Issue: 2024, Volume 30 - Issue 2
1847 943

Impulse control disorders related cognitive and behavioral features in Parkinson’s disease

Esra Erkoc Ataoglu, Yasemin Bozdağ, Ayse Bora Tokcaer

DOI: 10.55697/tnd.2024.109

Issue: 2024, Volume 30 - Issue 3
1232 788

The influence of self-care agency on quality of life in patients with multiple sclerosis

Ahsen Taştan Gürkan, Afitap Özdelikara

DOI: 10.55697/tnd.2024.9

Issue: 2024, Volume 30 - Issue 3
992 576

Scale consistance in cognitive status awareness of patients with Parkinson’s disease

Sabiha Tezcan Aydemir, Elif Yüsra Unutmaz, Pınar Özkan, Talha Abalı, Gülnur Ayık, Dudu Genç Batmaz, Sema Nur Kibrit, Ahmet Veli Karacan, Müge Kuzu Kumcu, Merve Koç Yekedüz, Fatma Tuba Eminoğlu, Rezzak Yılmaz, Muhittin Cenk Akbostancı

DOI: 10.55697/tnd.2024.139

Issue: 2024, Volume 30 - Issue 3
774 473

Could pulsed radiofrequency stimulation of the proximal greater occipital nerve be a treatment option for refractory chronic migraine patients?

Derya Yavuz Demiray, Ferhat Ege

DOI: 10.55697/tnd.2024.1

Issue: 2024, Volume 30 - Issue 4
947 591

Relationship between subjective sleep quality and serum ghrelin levels in Parkinson’s disease

Alper Ayaslı, Yıldız Değirmenci, Davran Fat, Mehmet Ali Sungur

DOI: 10.55697/tnd.2025.137

Issue: 2025, Volume 31 - Issue 1
417 258